Tumor Ablation Market is expected to expand at a CAGR of 13.5% from 2022 to 2030

Tumor Ablation Industry Overview

The global tumor ablation market size was valued at USD 1.14 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 13.5% from 2022 to 2030. The rising prevalence of cancer and the high demand for safer therapeutic options are major factors contributing to the growth of the market. According to the WHO, it is projected that around 10-11 million cancer cases will be diagnosed each year globally by 2030. The number of new cancer cases is expected to increase by more than 80% in low-income countries compared to half the rate in high-income countries (40%) from 2008 to 2030. Lucrative growth potential in currently available therapeutic options and high demand for minimally and non-invasive therapies are the factors expected to drive the market in the upcoming years.

Increasing inclination of surgeons and patients toward minimally invasive procedures owing to the benefits such as speedy recovery, patient comfort, and reduced turnaround time are the factors expected to drive the demand for advanced tumor ablation techniques over the forecast period. Advanced tumor ablation procedures are generally performed on an outpatient basis and do not require any hospital admission compared with conventional therapies, thereby significantly reducing the total healthcare cost. The ablative surgeries are the preferred therapy for tumors of smaller sizes. Thus, its procedural volume is indirectly dependent on the yearly cancer screening rates. The market was significantly impacted in 2020 as the number of newly diagnosed cancer cases significantly dropped during COVID owing to fewer screening initiatives undertaken by concerned authorities.

Gather more insights about the market drivers, restraints, and growth of the Global Tumor Ablation market

According to a report by the Our World in Data (OWD), a project by Global Change Data Lab, over 70% of cancer cases occur in people aged over 50 in 2017. The number is expected to increase proportionally with the rising geriatric population. The aging population comprises the main target population for noninvasive ablation techniques as the body’s biological functions get compromised with aging. Therefore, the rapidly increasing aging population is expected to boost the demand for tumor ablation techniques during the forecast period. 

Technological advancements to enhance accuracy, portability, and cost-effectiveness are the factors compelling market players to constantly improve and launch advanced devices. Image-guided equipment, HIFU, and cryoablation are major examples of these technological advancements. Usage of the cooled radiofrequency denervation technique with internally cooled radiofrequency probes to enlarge the size of the lesion is one of the emerging techniques that is anticipated to play a significant role in market expansion. This technique enables complete denervation of the sacroiliac joint, which helps in pain management.

Browse through Grand View Research's Medical Devices Industry Research Reports.

MRI Motion Tracking Systems Market - The global MRI motion tracking systems market size was valued at USD 2.7 million in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 20.76% from 2022 to 2030.

Gamma Knife Market - The global gamma knife market size was valued at USD 364.6 million in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 5.0% from 2022 to 2030.

Tumor Ablation Market Segmentation

Grand View Research has segmented the global tumor ablation market based on technology, treatment, application, and region:

Tumor Ablation Technology Outlook (Revenue, USD Million, 2017 - 2030)

• Radiofrequency Ablation
• Microwave Ablation
• Cryoablation
• Irreversible Electroporation
• Other Ablation Technologies

Tumor Ablation Treatment Outlook (Revenue, USD Million, 2017 - 2030)

• Surgical Ablation
• Laparoscopic Ablation
• Percutaneous Ablation

Tumor Ablation Application Outlook (Revenue, USD Million, 2017 - 2030)

• Kidney Cancer
• Liver Cancer
• Breast Cancer
• Lung Cancer
• Prostate Cancer
• Other Cancer

Tumor Ablation Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Market Share Insights

August 2019: Boston Scientific Corporation received Health Canada approval for its advanced cryoablation system named ICEfx™. The device has a smaller footprint, is portable, and is a powerful alternative to the existing cryoablation systems.

March 2018: Auris Health announced a partnership with Ethicon to develop robotically-assisted bronchoscopy tumor ablative systems.

Key Companies profiled:

Some prominent players in the global tumor ablation market include:

• Angiodynamics (Covidien)
• Boston Scientific Corporation
• Medtronic Plc
• Ethicon, Inc.
• Galil Medical Inc.
• Misonix Inc.
• HealthTronics
• Mermaid Medical
• Theraclion
• Chongqing Haifu Medical Technology Co., Ltd.
• HS Hospital Service S.P.A
• EDAP TMS S.A.

Order a free sample PDF of the Tumor Ablation Market Intelligence Study, published by Grand View Research.